Krka Logo

Krka

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Krka’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. The company's focus is on the development of high-quality own-brand generic pharmaceuticals, which offer added value, and are marketed under Krka's own brands. Our products are sold in over 70 countries. As part of our business strategy we have set the objective of balanced sales in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Krka. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-04 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 130.0 KB
2025-08-04 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-08-04 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 129.6 KB
2025-08-04 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.1 KB
2025-07-28 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 124.3 KB
2025-07-28 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.1 KB
2025-07-28 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 121.8 KB
2025-07-28 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.0 KB
2025-07-25 08:30
Interim Report
Press release
English 150.1 KB
2025-07-25 08:30
Interim Report
H1 2025 Unaudited Interim Report of the Krka Group and Krka, d.d
English 1.1 MB
2025-07-25 08:30
Report Publication Announcement
H1 2025 Unaudited Interim Report of the Krka Group and Krka, d. d.
English 1.1 KB
2025-07-25 08:30
Earnings Release
Sporočilo za javnost
Slovene 152.5 KB
2025-07-25 08:30
Interim Report
Nerevidirano poročilo o poslovanju skupine Krka in družbe Krka v prvem polletju…
Slovene 1.0 MB
2025-07-25 08:30
Report Publication Announcement
Nerevidirano poročilo o poslovanju skupine Krka in družbe Krka v prvem polletju…
Slovene 1.2 KB
2025-07-14 08:30
Post-Annual General Meeting Information
31st AGM Resolutions
English 188.9 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
TORII PHARMACEUTICAL CO., LTD. Japan 4551
TOWA PHARMACEUTICAL CO.,LTD. Logo TOWA PHARMACEUTICAL CO.,LTD. Japan 4553
TSUMURA & CO. Logo TSUMURA & CO. Japan 4540
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo TURK İLAÇ VE SERUM SANAYİ A.Ş. Türkiye TRILC
UCB Logo UCB Belgium UCB
Valneva SE Logo Valneva SE France VLA
VENTURE LIFE GROUP PLC Logo VENTURE LIFE GROUP PLC United Kingdom VLG
Vetoquinol SA Logo Vetoquinol SA France VETO
Vicore Pharma Holding Logo Vicore Pharma Holding Sweden VICO
Vifor Pharma AG Logo Vifor Pharma AG Switzerland VIFN